Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaomian Li

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 9, 2025
PP1A Modulates the Efficacy of Lenvatinib Plus ICIs Therapy by Inhibiting Ferroptosis in Hepatocellular CarcinomaJitong Zhou, Meng Gao, Shikun Zhang, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 20, 2025
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathwayXiaoling Wu, Yiran Chen, Wenzhi He, et al.
International Journal of Biological Sciences|April 20, 2026
CCT2 Orchestrates Glycolysis and Exosome-Mediated M2 Macrophage Polarization in HCC tumorigenesisWing-Wa Guo, Cairang Dongzhi, Tianyin Ma, et al.
Oncogene|May 16, 2024
TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylationXiaomian Li, Wenzhi He, Xi Chen, et al.
Cancer Research|August 21, 2025
The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular CarcinomaYingyi Liu, Fu-Sheng Liu, Jie Liu, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse modelsYang-Wen-Qing Zhang, Hui Ren, Minghe Zhang, et al.
Oncogenesis|June 2, 2022
USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome cYe Yao, Weijie Ma, Yonghua Guo, et al.
Cancer Letters|December 29, 2024
RNF5 exacerbates steatotic HCC by enhancing fatty acid oxidation via the improvement of CPT1A stabilityXi Chen, Yang-Wen-Qing Zhang, Hui Ren, et al.
Nature Communications|June 21, 2026
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosisYang-Wen-Qing Zhang, Xiaoyu Pan, Minghe Zhang, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemiaTiangen Wu, Xi Chen, Kequan Xu, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 9, 2025
PP1A Modulates the Efficacy of Lenvatinib Plus ICIs Therapy by Inhibiting Ferroptosis in Hepatocellular CarcinomaJitong Zhou, Meng Gao, Shikun Zhang, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 20, 2025
UBE2Q2 promotes tumor progression and glycolysis of hepatocellular carcinoma through NF-κB/HIF1α signal pathwayXiaoling Wu, Yiran Chen, Wenzhi He, et al.
International Journal of Biological Sciences|April 20, 2026
CCT2 Orchestrates Glycolysis and Exosome-Mediated M2 Macrophage Polarization in HCC tumorigenesisWing-Wa Guo, Cairang Dongzhi, Tianyin Ma, et al.
Oncogene|May 16, 2024
TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylationXiaomian Li, Wenzhi He, Xi Chen, et al.
Cancer Research|August 21, 2025
The Acetyltransferase ARD1 Induces Glutathione Synthesis to Facilitate Ferroptosis Evasion in Hepatocellular CarcinomaYingyi Liu, Fu-Sheng Liu, Jie Liu, et al.
JHEP Reports : Innovation in Hepatology|March 11, 2026
CAR-T cells targeting activated hepatic stellate cells ameliorate liver fibrosis in mouse modelsYang-Wen-Qing Zhang, Hui Ren, Minghe Zhang, et al.
Oncogenesis|June 2, 2022
USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome cYe Yao, Weijie Ma, Yonghua Guo, et al.
Cancer Letters|December 29, 2024
RNF5 exacerbates steatotic HCC by enhancing fatty acid oxidation via the improvement of CPT1A stabilityXi Chen, Yang-Wen-Qing Zhang, Hui Ren, et al.
Nature Communications|June 21, 2026
Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosisYang-Wen-Qing Zhang, Xiaoyu Pan, Minghe Zhang, et al.
Hepatology (Baltimore, Md.)|September 7, 2023
LIM domain only 7 negatively controls nonalcoholic steatohepatitis in the setting of hyperlipidemiaTiangen Wu, Xi Chen, Kequan Xu, et al.
Pageof 3